![Lawrence Kenyon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence Kenyon
Finansdirektör/CFO på
OUTLOOK THERAPEUTICS, INC.
Förmögenhet: 104 496 $ per 2026-07-31
Profil
Currently, Lawrence A. Kenyon is CFO, Secretary, Treasurer, Director, and Executive VP at Outlook Therapeutics, Inc. since 2015.
Formerly, served as President, CEO, CFO, and Secretary at Tamir Biotechnology, Inc. in 2013; Director at Tamir Biotechnology, Inc. in 2009; Chief Financial Officer and Executive Vice President at Endo Generics Holdings, Inc. from 2009 to 2010; Chief Financial Officer, Secretary, and EVP at NeoPharm, Inc. from 2000 to 2006; Chief Financial Officer at Par Pharmaceutical, Inc. from 2009 to 2010; and Chief Operating and Financial Officer at Arno Therapeutics, Inc. from 2014 to 2015.
Education includes an undergraduate degree from the University of Wisconsin, conferred in 1987.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-14 | 106 956 ( 0,04 % ) | 104 496 $ | 2026-07-31 |
Aktiva positioner av Lawrence Kenyon
| Företag | Position | Start |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Finansdirektör/CFO | 2018-06-18 |
Tidigare kända positioner av Lawrence Kenyon
| Företag | Position | Slut |
|---|---|---|
| ARNO THERAPEUTICS, INC. | Finansdirektör/CFO | 2015-09-01 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Verkställande Direktör | 2013-03-31 |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Finansdirektör/CFO | 2010-07-01 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Finansdirektör/CFO | 2010-06-04 |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Finansdirektör/CFO | 2009-02-01 |
Lawrence Kenyons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
88
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Health Technology |
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States | Health Technology |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology Provides drug research, development and commercialization services | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Health Technology |
Arno Therapeutics, Inc.
 Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
